Assessment of Chemosensitivity-related Aberrant Methylation of Nonsmall Cell Lung Cancer by EBUS-TBNA
- 1 January 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Bronchology & Interventional Pulmonology
- Vol. 16 (1), 10-14
- https://doi.org/10.1097/lbr.0b013e318195d930
Abstract
Multigene aberrant methylation profiling may predict response to chemotherapy in lung cancer. The purpose of this study was to analyze the feasibility of detecting aberrant methylation in biopsy samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Lymph node samples from 30 patients with nonsmall cell lung cancer diagnosed as metastatic carcinoma by EBUS-TBNA were analyzed. Histologic cores obtained by EBUS-TBNA were separately stored at -80°C. DNA was extracted from EBUS-TBNA samples and bisulfate modification was performed. We evaluated the methylation status of a panel of 6 genes (FANCF, Reprimo, TMS1/ASC, activated protein-2α, CHFR, and ATM) using methylation-specific polymerase chain reaction. Twenty-four patients with adenocarcinoma or squamous cell carcinoma metastasis received platinum-based combination chemotherapy. We reviewed their response to chemotherapy in correlation to the methylation status. Bisulfate modification was successfully performed in all samples using DNA obtained from EBUS-TBNA samples by checking p16 unmethylation expression. Aberrant methylation was detected as follows: 9 cases of FANCF (30.0%), 14 cases of Reprimo (46.7%), 10 cases of TMS1/ASC (33.3%), and 19 cases of activated protein-2α (63.3%). In response to chemotherapy, there were 1 complete response, 6 partial response, 12 stable disease, and 5 progressive disease (PD) cases. The number of methylated genes was significantly smaller in the PD group than in the non-PD groups (P=0.0435). Aberrant methylation analysis can be performed in metastatic lymph nodes sampled by EBUS-TBNA. EBUS-TBNA allows for genetic evaluations of tumor cells and may help to guide the most effective treatment strategies in the near future.Keywords
This publication has 29 references indexed in Scilit:
- Advances in Chemotherapy of Non-small Cell Lung CancerChest, 2006
- Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodesThorax, 2006
- Comparison of Endobronchial Ultrasound, Positron Emission Tomography, and CT for Lymph Node Staging of Lung CancerChest, 2006
- Predicting the outcome of chemotherapy for lung cancerCurrent Opinion in Pharmacology, 2006
- Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinumEuropean Respiratory Journal, 2006
- Epigenetics as a mechanism driving polygenic clinical drug resistanceBritish Journal of Cancer, 2006
- Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancerLung Cancer, 2005
- Optimizing First-Line Treatment Options for Patients with Advanced NSCLCThe Oncologist, 2005
- Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal stagingEuropean Respiratory Journal, 2005
- Real-time Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Mediastinal and Hilar Lymph NodesChest, 2004